ArticleDrug and alcohol dependence2018
Perceptions and practices addressing diversion among US buprenorphine prescribers.
Article in Drug and alcohol dependence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states.Drug and alcohol dependence · 2023Pooled it
- Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial.Drug and alcohol dependence · 2021Trial
- Examining the effects of pill counts on treatment retention in buprenorphine maintenance therapy.Drug and alcohol dependence reports · 2026Article
- Implementation facilitation improves readiness for emergency department-initiated buprenorphine to treat opioid use disorder.Journal of substance use and addiction treatment · 2025Article
- Dynamics of prescribing and accessing medications for opioid use disorder: a community-based systems analysis.Addiction research & theory · 2024Article
- Perceptions of stimulant and buprenorphine diversion and strategies to address it.Health affairs scholar · 2024Article
- Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA).Annals of medicine · 2023Article
- Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder.Journal of substance abuse treatment · 2022Article
- Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment.The western journal of emergency medicine · 2022Review
- PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.Addiction science & clinical practice · 2021Article
- "You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.The International journal on drug policy · 2020Article
- Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.Addiction science & clinical practice · 2020Article
- Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?The International journal on drug policy · 2020Article
- How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.JMIR public health and surveillance · 2020Observational
- Assessing the needs of front-line providers in addressing the opioid crisis in South Carolina.Journal of substance abuse treatment · 2020Article
- Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.Drug and alcohol dependence · 2019Article
- Perceived need and availability of psychosocial interventions across buprenorphine prescriber specialties.Addictive behaviors · 2019Article
- Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States.Annals of family medicine · 2019Article
- Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.Addiction science & clinical practice · 2019Article
- Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?Substance abuse · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundWhile there has been a dramatic increase in prescribing of buprenorphine for the treatment of opioid use disorder in the US, little is known about prescribers' attitudes and practices regarding buprenorphine diversion and how they relate to prescriber characteristics.
methodsA national random sample of buprenorphine prescribers (N = 1174) completed surveys from July 2014 to January 2017. Analyses examined relationships between prescriber and practice characteristics and prescriber perceptions and approaches regarding diversion.
resultsAmong this sample of buprenorphine prescribers, 79.0% (N = 898) reported assessing all patients for risk of buprenorphine diversion and misuse. A third of prescribers described diversion as a significant or very significant concern in their community. The majority of prescribers reported seeing patients on average at least every other week during the first 60 days of treatment, and the majority reported testing urine for buprenorphine to assess for diversion. Perceptions of diversion being a greater problem in their community (AOR 1.212, 95% CI 1.073-1.369) and use of medication counts (AOR 1.006, 95% CI 1.003-1.009) were associated with increased likelihood of terminating patients when diversion was suspected, while having expertise in addiction (AOR 0.526, 95% CI 0.406-0.682) or psychiatry (AOR 0.714, 95% CI 0.558-0.914) were associated with decreased odds of terminating treatment for suspected diversion.
conclusionsBuprenorphine prescribers report diversion is an important issue, and most prescribers report that they assess patients for diversion, though specific practices differ based on prescriber and practice characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.